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 What’s in a number? Accurate estimates of childhood 
tuberculosis 
There is growing recognition that children bear a 
substantial burden of tuberculosis morbidity and 
mortality. However, in regions where the diagnosis 
is contingent on smear microscopy, the burden 
attributable to children, who usually have paucibacillary 
disease, is grossly underestimated. The downstream 
ramiﬁ cations of inaccurate estimates include inadequate 
attention and funding for childhood tuberculosis 
surveillance, diagnosis, treatment, prevention, and 
research. In the absence of microbiologically based 
diagnoses, estimates of tuberculosis in children have 
been based on extrapolation from adult data. In this 
issue of The Lancet Global Health, Peter Dodd and 
colleagues1 provide new estimates of the burden of 
childhood tuberculosis in the 22 high-burden countries. 
By contrast with standard estimates that are contingent 
on paediatric case reporting, which varies widely 
between countries, these estimates used country-
speciﬁ c household-based and population-based data.
WHO ﬁ rst disaggregated paediatric data in 2012 
and has not included children with HIV infection in 
the estimates of mortality. The estimates by Dodd and 
colleagues diﬀ er substantially from WHO estimates in 
terms of incidence rates and the proportion of disease 
in children. The median number of incident cases in the 
high-burden countries (650 997, IQR 424 871–983 118), 
although almost 25% higher than the WHO global 
estimate of 530 000 paediatric cases in 2012,2 is more 
consistent with other estimates. Jenkins and colleagues3 
used data from a systematic review to estimate that, 
in 2010, almost 1 million children developed the 
disease. These higher estimates seem to reﬂ ect global 
population structure more accurately; roughly 25% of 
the world population is estimated to be younger than 
15 years, with a range of 15–49% (median 31%) in high-
burden countries.4 Dodd and colleagues also provided 
estimates of the burden of tuberculosis in HIV-infected 
children, which infrequently has been disaggregated 
from adult tuberculosis and HIV co-infection. The overall 
estimated case detection rate of 35% was substantially 
lower than the WHO estimate of 66% case detection 
in children. This ﬁ nding has profound implications for 
resource allocation and, combined with the estimated 
disparities in the burden of disease borne by children in 
the high-burden countries, prompts questions about 
how to make paediatric diagnosis and reporting easier. 
Although molecular methods such as Xpert MTB/RIF 
oﬀ er improved sensitivity over smear microscopy, their 
role is restricted to settings in which respiratory 
specimens can be obtained from younger children and 
to situations in which tuberculosis is suspected. Findings 
of a Peruvian study5 showed that a negative tuberculin 
skin test strongly predicted death in children admitted 
to hospital with tuberculosis, possibly because the 
diagnosis was considered initially but discarded on the 
basis of this insensitive test. 
Additionally, Dodd and colleagues modelled tuber-
culosis infection and estimated a prevalence of 
50 million infected children. Because infection is not 
reportable in most settings, few population-based 
infection estimates exist. The new estimates allow for 
future benchmarking of preventable disease cases (eg, 
young children who are household contacts of cases, 
who did not receive isoniazid preventive therapy, and 
who progressed to disease). Although several studies6 
have reported poor use of isoniazid preventive therapy 
as per WHO guidelines in young exposed children,7 
broader population-based estimates of infection would 
encourage countries to alter resource allocation to 
improve secondary prevention. 
The study by Dodd and colleagues provides a strong 
foundation for future studies attempting to model 
the burden of childhood tuberculosis. The model 
incorporates both social and epidemiological variables. 
It would be intriguing to apply the model to low-
incidence nations, where more complete paediatric data 
are available. If the model could be validated in these 
countries, conﬁ dence in its accuracy might be increased. 
Also of interest would be another sensitivity analysis 
changing the estimates of adult prevalence to see the 
eﬀ ect on estimates in children. Variables that could 
be included in future models include modelling risk of 
tuberculosis exposure outside the home, especially in 
high-incidence settings where up to 40% of exposures 
stem from non-household contacts.8 Finally, there is 
growing evidence that only a minority of adults with 
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culture-conﬁ rmed pulmonary tuberculosis produce 
culturable aerosols, which might be a better marker 
of infectiousness than smear positivity.9 Integration 
of these data into future models could result in more 
accurate estimates. 
The estimates of the burden of childhood tuberculosis 
provided by Dodd and colleagues are substantially 
higher than previous global estimates in high-burden 
countries. These ﬁ ndings show that what often has been 
taken as truth—that control of tuberculosis in adults will 
inevitably result in improved tuberculosis control for 
children—is fallacious as a stand-alone control strategy. 
Until the gap in case-detection and reporting is closed, 
children will continue to suﬀ er from insuﬃ  cient access 
to appropriate resources. The crucial role of childhood 
infection as a reservoir for future disease cases is ignored 
in many high-burden countries. Without improved 
case-detection and prevention strategies for children, 
it is diﬃ  cult to envisage the high-burden countries 
following the same downward trajectory of incidence 
rates seen by industrialised countries during the past 
several decades. 
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